PB
Peter Barrett
Angel InvestorModerateBarrett joined Atlas Venture, an early stage life sciences venture capital fund, in 2002 and is a partner in the life sciences group. Previo...
9
Investments
1
Exits
—
AUM
11.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Peter Barrett.
Investment Thesis & Strategy
Peter Barrett, as an angel investor, likely invests in various stages of companies within the life sciences sector, leveraging his experience at Atlas Venture to identify promising early-stage opportunities. He likely seeks companies with strong scientific foundations and high growth potential.
Investment Activity
Deals per year over the last 16 years
1
20010
20020
20030
20041
20051
20060
20071
20080
20090
20102
20110
20120
20132
20140
20151
2016Portfolio Companies
Selected investments from their portfolio of 9 companies
O
Obsidian Therapeutics
Biotech · Series A, 2016
S
Synlogic
Biotech · Series A, 2014
C
Cadent Therapeutics
Biotech · Series A, 2014
H
Harbour Antibodies
Biotech · Series A, 2011
R
Raze Therapeutics
Biotech · Seed, 2011
P
Posterous
Media/Content · Seed, 2008
Z
Zafgen
Biotech · Series A, 2006
I
InfaCare Pharmaceutical
Healthcare · Seed, 2005
M
Momenta Pharmaceuticals
Biotech · Series A, 2001
Notable Exits
CompanyTypeYearValue / Acquirer
PosterousAcquisition2018—
Frequently Asked Questions
Peter Barrett focuses on Seed, Series B, Series A stage investments.